Skip to main content

Table 4 Sub-group analysis of UACR based on hypertension or obesity

From: Niclosamide from an anthelmintic drug to a promising adjuvant therapy for diabetic kidney disease: randomized clinical trial

Hypertension

Niclosamide arm

Control arm

P value between arms

Percent change in normotensive

(n = 15)

(n = 17)

 < 0.001*

− 27% ± 6

17% ± 10

Percent change in hypertensive

(n = 15)

(n = 13)

 < 0.001*

− 21% ± 12

17% ± 25

Obesity

Niclosamide arm

Control arm

P value between arms

Percent change in non-obese

(n = 20)

(n = 18)

0.017*

− 27% ± 16

10% ± 11

Percent change in obese

(n = 10)

(n = 12)

 < 0.001*

− 17% ± 11

12% ± 27

  1. Values are expressed as mean ± SD
  2. UACR, urinary albumin to creatinine ratio
  3. *Significant difference (P < 0.05)